Multilevel dysregulation of STAT3 activation in ALK plus T/null cell lymphoma.

被引：0
|
作者：
Zhang, Q
Raghunath, PN
Majewski, M
Carpentieri, DF
Odum, N
Skorski, T
Wasik, MA
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Univ Copenhagen, DK-1168 Copenhagen, Denmark
[3] Temple Univ, Philadelphia, PA 19122 USA
来源：
FASEB JOURNAL | 2001年 / 15卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
下载
收藏
页码：A1180 / A1180
页数：1
相关论文
共 50 条
  • [21] Prognostic significance of STAT3 activation in systemic anaplastic large cell lymphoma
    Khoury, JD
    Medeiros, LJ
    Rassidakis, GZ
    Tsioli, P
    Leventaki, V
    Schmitt-Graeff, A
    Herling, M
    Sarris, AH
    Lai, R
    MODERN PATHOLOGY, 2003, 16 (01) : 239A - 240A
  • [22] IL-21 Contributes to JAK3/STAT3 Activation and Promotes Cell Growth in ALK-Positive Anaplastic Large Cell Lymphoma
    Bard, Jennifer Dien
    Gelebart, Pascal
    Anand, Mona
    Zak, Zoulika
    Hegazy, Samar A.
    Amin, Hesham M.
    Lai, Raymond
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (02): : 825 - 834
  • [23] Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion
    Momose, Shuji
    Tamaru, Jun-ichi
    Kishi, Hirohisa
    Mikata, Ittaku
    Mori, Masaya
    Toyozumi, Yasuo
    Itoyama, Shinji
    HUMAN PATHOLOGY, 2009, 40 (01) : 75 - 82
  • [24] Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
    Zamo, A
    Chiarle, R
    Piva, R
    Howes, J
    Fan, Y
    Chilosi, M
    Levy, DE
    Inghirami, G
    ONCOGENE, 2002, 21 (07) : 1038 - 1047
  • [25] Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
    Alberto Zamo
    Roberto Chiarle
    Roberto Piva
    Jennifer Howes
    Yan Fan
    Marco Chilosi
    David E Levy
    Giorgio Inghirami
    Oncogene, 2002, 21 : 1038 - 1047
  • [26] Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation
    Ashizawa, Tadashi
    Miyata, Haruo
    Ishii, Hidee
    Oshita, Chie
    Matsuno, Kenji
    Masuda, Yoshiaki
    Furuya, Toshio
    Okawara, Tadashi
    Otsuka, Masami
    Ogo, Naohisa
    Asai, Akira
    Akiyama, Yasuto
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (05) : 1245 - 1252
  • [27] Correlation of SOCS3 expression with STAT3 activation in mantle cell lymphoma (MCL)
    Yared, MA
    Medeiros, LJ
    Khoury, JD
    Rassidakis, GZ
    Leventaki, V
    Lai, R
    LABORATORY INVESTIGATION, 2003, 83 (01) : 260A - 260A
  • [28] Correlation of SOCS3 expression with STAT3 activation in mantle cell lymphoma (MCL)
    Yared, MA
    Medeiros, LJ
    Khoury, JD
    Rassidakis, GZ
    Leventaki, V
    Lai, R
    MODERN PATHOLOGY, 2003, 16 (01) : 260A - 260A
  • [29] The Activation of the JAK3/STAT3 Pathway Is Associated with Inferior Outcome in Diffuse Large B-cell Lymphoma and ALK-Positive Large B-cell Lymphoma
    Costinean, Stefan
    Zheng, Mei
    Huang, Xin
    Meng, Bin
    Smith, Lynette M.
    Appiah, Adams K.
    Hu, Shimin
    Zhou, Yi
    Pan, Zenggang
    Greiner, Timothy C.
    Qureishi, Hina N.
    Amador, Catalina
    Fu, Kai
    Yuan, Ji
    LABORATORY INVESTIGATION, 2016, 96 : 340A - 341A
  • [30] The Activation of the JAK3/STAT3 Pathway Is Associated with Inferior Outcome in Diffuse Large B-cell Lymphoma and ALK-Positive Large B-cell Lymphoma
    Costinean, Stefan
    Zheng, Mei
    Huang, Xin
    Meng, Bin
    Smith, Lynette M.
    Appiah, Adams K.
    Hu, Shimin
    Zhou, Yi
    Pan, Zenggang
    Greiner, Timothy C.
    Qureishi, Hina N.
    Amador, Catalina
    Fu, Kai
    Yuan, Ji
    MODERN PATHOLOGY, 2016, 29 : 340A - 341A
12345